Epilepsi hastasinda topiramatin indüklediği ekolali olgusu A case of echolalia in a topiramate induced patient with epilepsy

Echolalia are subsets of imitative behavior which repetition of sounds and language. Topiramate is an effective drug for treatment several types of seizures. It is generally tolerated well. We reported the case of a 44-year old man patient who presented with a history of a epilepsy disorder, He had been maintained with 1000 mg/day sodium valproate for seizure episode. But this recently did not control his seizure episode. Then he was placed on topiramate (600mg/day). Following treatment, he had no seizure episode. subsequently He became incoherence, confusion, disorientation, and significant speech impair ments including echolalia Thereby, we present a case of echolalia in a rapidly titrated topiramate induced in a epilepsy disorder patient. J Clin Exp Invest 2014; 5 (4): 620-622

[1]  Alexander Münchau,et al.  The pathophysiology of echopraxia/echolalia: Relevance to Gilles De La Tourette syndrome , 2012, Movement disorders : official journal of the Movement Disorder Society.

[2]  C. Supuran,et al.  Therapeutic applications of glycosidic carbonic anhydrase inhibitors , 2009, Medicinal research reviews.

[3]  P. Keck,et al.  Role of Antiepileptic Drugs in the Management of Eating Disorders , 2009, CNS drugs.

[4]  Xue-feng Wang,et al.  Tolerability and Safety of Topiramate in Chinese Patients with Epilepsy , 2007, Clinical drug investigation.

[5]  M. Reed,et al.  Intentional Topiramate Ingestion in an Adolescent Female , 2004, The Annals of pharmacotherapy.

[6]  G. Holmes,et al.  Mechanisms of Action for the Commonly Used Antiepileptic Drugs: Relevance to Antiepileptic Drug-Associated Neurobehavioral Adverse Effects , 2004, Journal of child neurology.

[7]  B. Abou-Khalil,et al.  Topiramate Overdose: Clinical and Laboratory Features , 2002, Epilepsy & Behavior.

[8]  Amanda G. Smith,et al.  Topiramate Overdose: A Case Report and Literature Review , 2001, Epilepsy & Behavior.

[9]  M.W. Jones,et al.  Topiramate - Safety and Tolerability , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[10]  R. Sachdeo.  Topiramate. Clinical profile in epilepsy. , 1998, Clinical pharmacokinetics.

[11]  B. Bourgeois,et al.  New antiepileptic drugs. , 1998, Archives of neurology.

[12]  R. Davis,et al.  Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. , 1997, Drugs.

[13]  W. Rosenfeld,et al.  Comparison of the Steady‐State Pharmacokinetics of Topiramate and Valproate in Patients with Epilepsy During Monotherapy and Concomitant Therapy , 1997, Epilepsia.

[14]  R. Nayak,et al.  Single‐Dose Pharmacokinetics and Effect of Food on the Bioavailability of Topiramate, A Novel Antiepileptic Drug , 1996, Journal of clinical pharmacology.